Stanford Blood Center: Implementing a 100% Pathogen Reduced Platelet Inventory
Stanford discusses its experience with adopting a 100% pathogen reduced inventory to streamline production and to meet increasing hospital demand.
Chief Operating Officer, Stanford Blood Center
Director of Operational Excellence, Stanford Blood Center
Read the Case Study:
Stanford Blood Center – The First Blood Center of its Size to Implement Pathogen Reduction for 100% of Platelet Components
Stanford Blood Center (SBC), a leader in the fields of transfusion and transplantation medicine, supplies >17,000 platelet products per year to Stanford and other area hospitals.